73,95 €
73,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
37 °P sammeln
73,95 €
73,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
37 °P sammeln
Als Download kaufen
73,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
37 °P sammeln
Jetzt verschenken
73,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
37 °P sammeln
  • Format: PDF

While the majority of patients with symptomatic coronary artery disease (CAD) achieve acceptable angina relief through medical therapy, coronary artery bypass grafting and percutaneous coronary intervention, a growing number are not candidates for these procedures. Standard procedures are largely palliative, and symptom recurrence is relatively common, while the increase in obesity and type 2 diabetes may result in a potential explosion in severe, diffuse CAD. As these trends continue, the population of patients who fail to achieve adequate symptomatic improvement through standard medical and…mehr

Produktbeschreibung
While the majority of patients with symptomatic coronary artery disease (CAD) achieve acceptable angina relief through medical therapy, coronary artery bypass grafting and percutaneous coronary intervention, a growing number are not candidates for these procedures. Standard procedures are largely palliative, and symptom recurrence is relatively common, while the increase in obesity and type 2 diabetes may result in a potential explosion in severe, diffuse CAD. As these trends continue, the population of patients who fail to achieve adequate symptomatic improvement through standard medical and revascularization strategies will grow exponentially. Therapeutic options for these patients are currently limited, but experimental and developing strategies are appearing, including transmyocardial laser revascularization, therapeutic angiogenesis, spinal cord stimulation, external counterpulsation, various novel medical therapies and complex percutaneous and surgical revascularization strategies.

Coronary Artery Disease: New Approaches without Traditional Revascularization is a comprehensive and clinically oriented review of the epidemiology and basic science foundation for studies in this challenging group of patients. Current and novel treatment strategies are put in the context of past failures and future directions, and the Editors and their carefully chosen group of contributors provide a fascinating insight into the direction and focus for clinical practice and research in this area. As such this book is an important reference not only for clinical cardiologists, cardiac surgeons and interventionalists but also researchers into novel diagnostic measures, new surgical techniques and other treatment regiments in CAD.


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Coronary Artery Disease will be directed towards individuals with an interest in the clinical treatment of patients with unrevascularizable angina. It will explore a variety of treatment options in the setting of a sound scientific background and provide guidance and predictions for future direction in this rapidly developing field. As the only textbook of its kind, it will fulfill an unmet need and is likely to be greeted with significant enthusiasm by the practicing internal medicine, family practice and cardiovascular clinicians. It will also provide a reliable reference for clinical and basic researchers interested in this topic, as well as affected patients and their families.